Skip to content

CORE LABORATORIES N V

Delisted

CIK 1000229fmd_0204XNT6SAKRC1CMGBS5QC4RBBMining · Oil & Gas Field Services, NECTemplate: Standard

Coverage: Jan 01, 2008 to Mar 31, 2023, 57 periods

Latest annual · FY2022

Millions
Total revenues
490
Operating income
42
Net income
19
Free cash flow
15

Latest quarter · Q1 FY2023

Millions
Total revenues
128
Operating income
6
Net income
2
Free cash flow
(5)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2019 to FY2022
-9.8%
Revenue, 5 yearsFY2017 to FY2022
-5.4%
Net income, 5 yearsFY2017 to FY2022
-25.2%

CORE LABORATORIES N V financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Revenue$489.7 million$470.3 million+4.1%10-K 2023-02-10 · proof
Operating income$41.5 million$45.3 million-8.3%10-K 2023-02-10 · proof
Net income$19.5 million$19.7 million-1.4%10-K 2023-02-10 · proof
Cash from operating activities$25 million$36.6 million-31.8%10-K 2023-02-10 · proof
Free cash flow$14.7 million$23 million-36%10-K 2023-02-10 · proof
Total assets$578.4 million$580.9 million-0.4%10-K 2023-02-10 · proof
Total liabilities$389.4 million$419.9 million-7.3%10-K 2023-02-10 · proof
Cash and cash equivalents$15.4 million$17.7 million-12.9%10-K 2023-02-10 · proof
What was CORE LABORATORIES N V's revenue in fiscal 2022?
CORE LABORATORIES N V reported revenue of $489.7 million for fiscal 2022 (the year ended Dec 31, 2022), against $470.3 million the year before (+4.1%). Source: the 10-K filed with the SEC on Feb 10, 2023. SEC
What was CORE LABORATORIES N V's operating income in fiscal 2022?
CORE LABORATORIES N V reported operating income of $41.5 million for fiscal 2022 (the year ended Dec 31, 2022), against $45.3 million the year before (-8.3%). Source: the 10-K filed with the SEC on Feb 10, 2023. SEC
What was CORE LABORATORIES N V's net income in fiscal 2022?
CORE LABORATORIES N V reported net income of $19.5 million for fiscal 2022 (the year ended Dec 31, 2022), against $19.7 million the year before (-1.4%). Source: the 10-K filed with the SEC on Feb 10, 2023. SEC
What was CORE LABORATORIES N V's cash from operating activities in fiscal 2022?
CORE LABORATORIES N V reported cash from operating activities of $25 million for fiscal 2022 (the year ended Dec 31, 2022), against $36.6 million the year before (-31.8%). Source: the 10-K filed with the SEC on Feb 10, 2023. SEC
What was CORE LABORATORIES N V's free cash flow in fiscal 2022?
CORE LABORATORIES N V reported free cash flow of $14.7 million for fiscal 2022 (the year ended Dec 31, 2022), against $23 million the year before (-36%). Source: the 10-K filed with the SEC on Feb 10, 2023. SEC
What are CORE LABORATORIES N V's total assets?
As of Dec 31, 2022, CORE LABORATORIES N V reported total assets of $578.4 million, against $580.9 million a year earlier (-0.4%). Source: the 10-K filed with the SEC on Feb 10, 2023. SEC
What are CORE LABORATORIES N V's total liabilities?
As of Dec 31, 2022, CORE LABORATORIES N V reported total liabilities of $389.4 million, against $419.9 million a year earlier (-7.3%). Source: the 10-K filed with the SEC on Feb 10, 2023. SEC
What are CORE LABORATORIES N V's cash and cash equivalents?
As of Dec 31, 2022, CORE LABORATORIES N V reported cash and cash equivalents of $15.4 million, against $17.7 million a year earlier (-12.9%). Source: the 10-K filed with the SEC on Feb 10, 2023. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1000229&period_type=annual&limit=5"

Information only, not investment advice.